{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cell migration", "cell viability", "medicinal plants", "multi drug resistance", "tyrosinase"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33071779", "DateRevised": {"Year": "2020", "Month": "10", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "09", "Day": "15"}], "Language": ["eng"], "ELocationID": ["546439", "10.3389/fphar.2020.546439"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Effects of Selected Nigerian Medicinal Plants on the Viability, Mobility, and Multidrug-Resistant Mechanisms in Liver, Colon, and Skin Cancer Cell Lines.", "Pagination": {"StartPage": "546439", "MedlinePgn": "546439"}, "Abstract": {"AbstractText": ["Medicinal plants indicated for chronic diseases usually have good safety margins as they are intended for lifelong treatments. We hypothesized that they may provide patients with baseline protection to cancers and multidrug resistance-reversing phytochemicals resulting in successful prevention and/or adjuvant treatment of chemotherapy-resistant cancers. We selected 27 popular herbal infusions widely used in Nigeria for diabetes and studied their effects on a panel of liver (HepG2), colon (Caco2), and skin (B16-F10) cancer cells. Cytotoxicity was measured using the SRB staining assay. The 2D antimigratory effect was evaluated using an Oris\u2122 platform. The P-glycoprotein (P-gp) efflux activity was evaluated using Rh-123 as a fluorescent probe. The inhibition of tyrosinase-mediated melanogenesis was evaluated by colorimetric enzymatic assays. Our results show that melanoma cell proliferation was strongly inhibited by <i>Anogeissus leiocarpus</i> (Combretaceae)<i>, Bridelia ferruginea</i> (Phyllanthaceae), <i>D. ogea</i> (Leguminosae), and <i>Syzygium guineense</i> (Myrtaceae) extracts (G<sub>I50 =</sub> 50 \u00b5g/ml). <i>Alstonia boonei</i> (Apocynaceae), <i>Gongronema latifolium</i> (Asclepiadaceae), and <i>Strophanthus hispidus</i> (Apocynaceae) were preferentially toxic against Caco2 (GI<sub>50 =</sub> 50, 5 and 35 \u00b5g/ml, respectively). The most active extracts against different drug resistance mechanisms were <i>B. ferruginea</i> (inhibition of P-gp efflux, and impairing tyrosinase activity) and <i>X. americana</i> (inhibition of P-gp efflux). <i>A. leiocarpus, Kaya senegalensis</i> (Meliaceae), <i>S. guineense</i>, and <i>Terminalia avicennioides</i> (Combretaceae) significantly inhibited B16-F10 cell migration. Lupeol, ursolic acid, quercitrin, epicatechin, gallic acid, and ellagic acid were dereplicated by HPLC and HPTLC as their bioactive phytochemicals. In conclusion, the above in-vitro activities of herbal infusions regularly consumed by Nigerian diabetic patients may either act as a baseline chemoprotection or as sensitizing agents."], "CopyrightInformation": "Copyright \u00a9 2020 AlQathama, Ezuruike, Mazzari, Yonbawi, Chieli and Prieto."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, University College London, London, United Kingdom."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "AlQathama", "ForeName": "Aljawharah", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, University College London, London, United Kingdom."}], "LastName": "Ezuruike", "ForeName": "Udoamaka F", "Initials": "UF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, University College London, London, United Kingdom."}], "LastName": "Mazzari", "ForeName": "Andre L D A", "Initials": "ALDA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, University College London, London, United Kingdom."}, {"Identifier": [], "Affiliation": "Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia."}], "LastName": "Yonbawi", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy."}], "LastName": "Chieli", "ForeName": "Elisabetta", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, University College London, London, United Kingdom."}], "LastName": "Prieto", "ForeName": "Jose M", "Initials": "JM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alqathama A., Prieto J. M. (2015). Natural products with therapeutic potential in melanoma metastasis. Nat. Prod. Rep. 32, 1170\u20131182. 10.1039/C4NP00130C", "ArticleIdList": ["10.1039/C4NP00130C", "26018751"]}, {"Citation": "Aung T. N., Qu Z., Kortschak R. D., Adelson D. L. (2017). Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action. Int. J. Mol. Sci. 18, 656. 10.3390/ijms18030656", "ArticleIdList": ["10.3390/ijms18030656", "PMC5372668", "28304343"]}, {"Citation": "Chen K. G., Valencia J. C., Lai B., Zhang G., Paterson J. K., Rouzaud F., et al. (2006). Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc. Natl. Acad. Sci. U. States America 103, 9903\u20139907. 10.1073/pnas.0600213103", "ArticleIdList": ["10.1073/pnas.0600213103", "PMC1502551", "16777967"]}, {"Citation": "Chieli E., Romiti N., Rodeiro I., Garrido G. (2009). In vitro effects of Mangifera indica and polyphenols derived on ABCB1/P-glycoprotein activity. Food Chem. Toxicol. 47, 2703\u20132710. 10.1016/j.fct.2009.07.017", "ArticleIdList": ["10.1016/j.fct.2009.07.017", "19632288"]}, {"Citation": "Chieli E., Romiti N., Rodeiro I., Garrido G. (2010). In vitro modulation of ABCB1/P-glycoprotein expression by polyphenols from Mangifera indica. Chem. Biol. Interact. 186, 287\u2013294. 10.1016/j.cbi.2010.05.012", "ArticleIdList": ["10.1016/j.cbi.2010.05.012", "20513373"]}, {"Citation": "Corley D. G., Durley R. C. (1994). Strategies for database dereplication of natural products. J. Natural Prod. 57, 1484\u20131490. 10.1021/np50113a002", "ArticleIdList": ["10.1021/np50113a002"]}, {"Citation": "Dallavalle S., Dobri\u010di\u0107 V., Lazzarato L., Gazzano E., Machuqueiro M., Pajeva I., et al. (2020). Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Drug Resist. Update 50, 100682. 10.1016/j.drup.2020.100682", "ArticleIdList": ["10.1016/j.drup.2020.100682", "32087558"]}, {"Citation": "Ezuruike U. F., Prieto J. M. (2014). The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations. J. Ethnopharmacol. 155, 857\u2013924. 10.1016/j.jep.2014.05.055", "ArticleIdList": ["10.1016/j.jep.2014.05.055", "24929108"]}, {"Citation": "Ezuruike U. F., Chieli E., Prieto J. M. (2019). In Vitro Modulation of Glibenclamide Transport by P-glycoprotein Inhibitory Antidiabetic African Plant Extracts. Planta Med. 85, 987\u2013996. 10.1055/a-0948-9072", "ArticleIdList": ["10.1055/a-0948-9072", "31350736"]}, {"Citation": "Giner R. M., Recio M. C., Cuellar M. J., M\u00e1\u00f1ez S., Peris J. B., St\u00fcbing G., et al. (1993). A Taxonomical Study of the Subtribe Leontodontinae Based on the Distribution of Phenolic Compounds. Biochem. Syst. Ecol. 21, 613\u2013616. 10.1016/0305-1978(93)90061-U", "ArticleIdList": ["10.1016/0305-1978(93)90061-U"]}, {"Citation": "Hodek P., Kr\u00edzkov\u00e1 J., Burdov\u00e1 K., Sulc M., Kizek R., Hudecek J., et al. (2009). Chemopreventive compounds\u2013view from the other side. Chem. Biol. Interact. 180, 1\u20139. 10.1016/j.cbi.2009.01.003", "ArticleIdList": ["10.1016/j.cbi.2009.01.003", "19428340"]}, {"Citation": "\nInternational Agency for Research on Cancer \nI. Global Cancer Observatory [Online]. Available at: https://gco.iarc.fr/ (Accessed 2020 2020)."}, {"Citation": "Jedy-Agba E., Curado M. P., Ogunbiyi O., Oga E., Fabowale T., Igbinoba F., et al. (2012). Cancer incidence in Nigeria: A report from population-based cancer registries. Cancer Epidemiol. 36, e271\u2013e278. 10.1016/j.canep.2012.04.007", "ArticleIdList": ["10.1016/j.canep.2012.04.007", "PMC3438369", "22621842"]}, {"Citation": "Kitagawa S., Nabekura T., Kamiyama S., Kitagawa S. (2004). Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. JPP 56, 1001\u20131005. 10.1211/0022357044003", "ArticleIdList": ["10.1211/0022357044003", "15285844"]}, {"Citation": "Masuda T., Fujita N., Odaka Y., Takeda Y., Yonemori S., Nakamoto K., et al. (2007). Tyrosinase inhibitory activity of ethanol extracts from medicinal and edible plants cultivated in okinawa and identification of a water-soluble inhibitor from the leaves of Nandina domestica. Biosci. Biotechnol. Biochem. 71, 2316\u20132320. 10.1271/bbb.70249", "ArticleIdList": ["10.1271/bbb.70249", "17827684"]}, {"Citation": "\nNational Cancer Institute  (2020). NCI-60 Screening Methodology. [Online]. Available at: https://dtp.cancer.gov/discovery_development/nci-60/methodology.htm (Accessed 2018 2018)."}, {"Citation": "Ozben T. (2006). Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett. 580, 2903\u20132909. 10.1016/j.febslet.2006.02.020", "ArticleIdList": ["10.1016/j.febslet.2006.02.020", "16497299"]}, {"Citation": "Pan M. H., Ho C. T. (2008). Chemopreventive effects of natural dietary compounds on cancer development. Chem. Soc. Rev. 37, 2558\u20132574. 10.1039/b801558a", "ArticleIdList": ["10.1039/b801558a", "18949126"]}, {"Citation": "Pinon A., Limami Y., Micallef L., Cook-Moreau J., Liagre B., Delage C., et al. (2011). A novel form of melanoma apoptosis resistance: melanogenesis up-regulation in apoptotic B16-F0 cells delays ursolic acid-triggered cell death. Exp. Cell Res. 317, 1669\u20131676. 10.1016/j.yexcr.2011.04.014", "ArticleIdList": ["10.1016/j.yexcr.2011.04.014", "21565187"]}, {"Citation": "Skehan P., Storeng R., Scudiero D., Monks A., Mcmahon J., Vistica D., et al. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107\u20131112. 10.1093/jnci/82.13.1107", "ArticleIdList": ["10.1093/jnci/82.13.1107", "2359136"]}, {"Citation": "Suffness M., Pezzuto J. (1999). Assays related to cancer drug discovery (London: Academic Press; )."}, {"Citation": "Syed S. B., Coumar M. S. (2016). P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design. Curr. Top. Med. Chem. 16, 2484\u20132508. 10.2174/1568026616666160212123814", "ArticleIdList": ["10.2174/1568026616666160212123814", "26873188"]}, {"Citation": "Tan K. W., Li Y., Paxton J. W., Birch N. P., Scheepens A. (2013). Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2). Food Chem. 138, 2267\u20132274. 10.1016/j.foodchem.2012.12.021", "ArticleIdList": ["10.1016/j.foodchem.2012.12.021", "23497885"]}, {"Citation": "The African Cancer Registry Network Nigerian National System of Cancer Registries ."}, {"Citation": "Thomford N. E., Senthebane D. A., Rowe A., Munro D., Seele P., Maroyi A., et al. (2018). Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery. Int. J. Mol. Sci. 19, 1578. 10.3390/ijms19061578", "ArticleIdList": ["10.3390/ijms19061578", "PMC6032166", "29799486"]}, {"Citation": "Tinoush B., Shirdel I., Wink M. (2020). Phytochemicals: Potential Lead Molecules for MDR Reversal. Front. Pharmacol. 11, 832. 10.3389/fphar.2020.00832", "ArticleIdList": ["10.3389/fphar.2020.00832", "PMC7317022", "32636741"]}, {"Citation": "Viale A., Draetta G. F. (2016). Metabolic Features of Cancer Treatment Resistance. Recent Results Cancer Res. 207, 135\u2013156. 10.1007/978-3-319-42118-6_6", "ArticleIdList": ["10.1007/978-3-319-42118-6_6", "27557537"]}, {"Citation": "Yan X. -J., Gong L. -H., Zheng F. -Y., Cheng K. -J., Chen Z. -S., Shi Z., et al. (2014). Triterpenoids as reversal agents for anticancer drug resistance treatment. Drug Discov. Today 19, 482\u2013488. 10.1016/J.DRUDIS.2013.07.018", "ArticleIdList": ["10.1016/J.DRUDIS.2013.07.018", "23954181"]}, {"Citation": "Zhang H.-M., Zhao L., Li H., Xu H., Chen W.-W., Tao L. (2014). Research progress on the anticarcinogenic actions and mechanisms of ellagic acid. Cancer Biol. Med. 11, 92\u2013100. 10.7497/j.issn.2095-3941.2014.02.004", "ArticleIdList": ["10.7497/j.issn.2095-3941.2014.02.004", "PMC4069806", "25009751"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "3", "Day": "28"}, {"Year": "2020", "Month": "8", "Day": "26"}, {"Year": "2020", "Month": "10", "Day": "19", "Hour": "5", "Minute": "54"}, {"Year": "2020", "Month": "10", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "9", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["33071779", "PMC7533547", "10.3389/fphar.2020.546439"]}}], "PubmedBookArticle": []}